Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K was filed on February 28, 2013, for the month of February 2013. The filing serves as a notification that the Company has submitted its Annual Report for the fiscal year 2012 on Form 20-F to the U.S. Securities and Exchange Commission.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced Annual Report (Form 20-F) and the attached Investor News Release (Exhibit 99.1), which are not included in the provided text.
Material Changes
No material changes regarding financial performance or operations are detailed in this specific filing text. The document solely announces the submission of the 2012 annual report.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. Investors must refer to the full Form 20-F for this information.
Investor Verification Checklist
- Verify the contents of the Annual Report 2012 filed on Form 20-F.
- Review the Investor News Release dated February 27, 2013 (Exhibit 99.1) for specific financial highlights.
- Confirm the filing date and signature authorization by CEO Rice Powell and CFO Michael Brosnan.